ClearShares Ultra-Short Maturity ETF OPER 深 沪
等待开盘 10-29 09:30:00 美东时间
100.365
+0.035
+0.03%
华盛通- 最 高100.37
- 今 开100.35
- 成交量 953股
- 最 低 100.35
- 昨 收 100.33
- 总市值 1.41亿
- 52周最高 100.37
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 96.1261
- 委 比 0.00%
- 总股本 140.00万
- 历史最高 100.37
- 量 比 0.11
- 振 幅 0.02%
- 历史最低 80.7987
- 每 手 1
- 风险率 1.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多GRUPO SIMEC ANNOUNCES RESULTS OF OPERATIONS FOR THE FIRST NINE MONTHS OF 2025
GUADALAJARA, Mexico, Oct. 27, 2025 /PRNewswire/ -- Grupo Simec, S.A.B. de C.V. (NYSE: SIM) (BMV: SIMEC-B) ("Simec") announced today its results of operations for the nine-month period ended ...
10-28 07:59
NOBLE CORPORATION PLC ANNOUNCES THIRD QUARTER 2025 RESULTS
Approximately $740 million in new contract value since August fleet status report, backlog increased to $7.0 billion. $0.50 per share cash dividend declared for Q4, bringing 2025 total share...
10-28 04:05
一周财经日历 |下周重磅事件抢先看：美联储利率决议、科技巨头财报密集来袭
重磅周！靴子落地？美联储将公布利率决议，预计降息25个基点；苹果、谷歌、微软等巨头财报密集来袭；港股下周三休市一天>>
10-25 16:40
General Dynamics Reports Third-Quarter 2025 Financial Results
Revenue $12.9 billion, up 10.6% from year-ago quarter Diluted EPS $3.88, up 15.8% from year-ago quarter $2.1 billion cash from operating activities, 199% of net earnings Very strong order ac...
10-24 19:00
BOYD GAMING REPORTS THIRD-QUARTER 2025 RESULTS
LAS VEGAS, Oct. 23, 2025 /PRNewswire/ -- Boyd Gaming Corporation (NYSE: BYD) today reported financial results for the third quarter ended September 30, 2025. Keith Smith, President and Chief...
10-24 04:05
IBM RELEASES THIRD-QUARTER RESULTS
Acceleration in revenue growth and profit across all segments; Raises outlook for full-year revenue growth and free cash flow ARMONK, N.Y., Oct. 22, 2025 /PRNewswire/ -- IBM (NYSE: IBM) toda...
10-23 04:08
Boston Scientific announces results for third quarter 2025
MARLBOROUGH, Mass., Oct. 22, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a ...
10-22 18:30
Reported Saturday, Olema Oncology Reports 15.5-Month Median Progression-Free Survival With Palazestrant Plus Ribociclib In ER-Positive, HER2-Negative Metastatic Breast Cancer At ESMO 2025
Palazestrant in combination with ribociclib demonstrated encouraging activity across all dose cohorts and subgroupsMedian PFS was 15.5 months in the 120 mg palazestrant cohort across all patientsIn the 120 mg
10-20 16:26
American Express Q3 FY2025 Earnings Call Transcript
Here is the American Express Q3 FY2025 earnings call transcript.
10-17 22:53
Delta Air Lines Q3 FY2025 Earnings Call Transcript
Here is the transcript of Delta Air Lines' Q3 FY2025 earnings call.
10-10 00:37
